Literature DB >> 27470439

Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.

David W Roberts1, Anne Marie Api2, Aynur O Aptula3.   

Abstract

The Local Lymph Node Assay (LLNA) is the most common in vivo regulatory toxicology test for skin sensitisation, quantifying potency as the EC3, the concentration of chemical giving a threefold increase in thymidine uptake in the local lymph node. Existing LLNA data can, along with clinical data, provide useful comparator information on the potency of sensitisers. Understanding of the biological variability of data from LLNA studies is important for those developing non-animal based risk assessment approaches for skin allergy. Here an existing set of 94 EC3 values for 12 chemicals, all tested at least three times in the same vehicle have been analysed by calculating standard deviations (SD) for logEC3 values. The SDs range from 0.08 to 0.22. The overall SD for the 94 logEC3 values is 0.147. Thus the 95% confidence limits (2xSD) for LLNA EC3 values are within a factor of 2, comparable to those for physico-chemical measurements such as partition coefficients and solubility. The residual SDs of Quantitative Mechanistic Models (QMMs) based on physical organic chemistry parameters are similar to the overall SD of the LLNA, indicating that QMMs of this type are unlikely to be bettered for predictive accuracy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biological variability; LLNA; Non-animal prediction; QMM

Mesh:

Substances:

Year:  2016        PMID: 27470439     DOI: 10.1016/j.yrtph.2016.07.013

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  3 in total

1.  Application of Defined Approaches for Skin Sensitization to Agrochemical Products.

Authors:  Judy Strickland; James Truax; Marco Corvaro; Raja Settivari; Joseph Henriquez; Jeremy McFadden; Travis Gulledge; Victor Johnson; Sean Gehen; Dori Germolec; David G Allen; Nicole Kleinstreuer
Journal:  Front Toxicol       Date:  2022-05-02

Review 2.  Non-animal methods to predict skin sensitization (II): an assessment of defined approaches *.

Authors:  Nicole C Kleinstreuer; Sebastian Hoffmann; Nathalie Alépée; David Allen; Takao Ashikaga; Warren Casey; Elodie Clouet; Magalie Cluzel; Bertrand Desprez; Nichola Gellatly; Carsten Göbel; Petra S Kern; Martina Klaric; Jochen Kühnl; Silvia Martinozzi-Teissier; Karsten Mewes; Masaaki Miyazawa; Judy Strickland; Erwin van Vliet; Qingda Zang; Dirk Petersohn
Journal:  Crit Rev Toxicol       Date:  2018-02-23       Impact factor: 5.635

3.  Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods.

Authors:  S Casati; K Aschberger; J Barroso; W Casey; I Delgado; T S Kim; N Kleinstreuer; H Kojima; J K Lee; A Lowit; H K Park; M J Régimbald-Krnel; J Strickland; M Whelan; Y Yang; Valérie Zuang
Journal:  Arch Toxicol       Date:  2017-11-10       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.